From Local to Global: The Power of Centralized Hubs

To centralize or not to centralize? Join us for this webinar and learn what to consider before moving clinical trial activities to centralized hubs.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/centralized-hubs

Event overview

As drug development costs and timelines increase, sponsors seek creative solutions to balance expenses without compromising quality or speed. While relocating resources to lower-cost countries can be effective, it faces limitations, such as availability of talent, or locality issues, such as time-zone requirements or the need for local-level expertise or presence. By relocating activities that do not need to be performed by country-specific staff to cost optimized hubs, sponsors can optimize their workforce and achieve cost, quality and efficiency gains if executed correctly.

This webinar will explore the different types of activities that can be transitioned to low-cost hubs and how to avoid some of the pitfalls and risks associated with such a strategy, demonstrated by real-life examples.

Three key take-aways

• How to decide which activities could/should be in scope for centralization based on real case findings
  
• How to plan and implement a centralization strategy
  
• How to ensure your centralization strategy yields the required benefits.

Speakers:

Claire Rielly
VP, Clinical Project Management
IQVIA
As vice president of clinical project management at IQVIA, Claire Rielly heads hybrid strategy for FSP and study management. Rielly has oversight of both RSU and clinical project management functions. She has more than 20 years of clinical experience; initially beginning her career in clinical research in 1998 as a clinical research associate. She has worked in that role and as clinical lead and line manager in both clinical research organizations and pharmaceutical settings.

Since 2016, Rielly has held leadership roles—including associate director, director, and senior director— for multiple FSP accounts and became regional head for EMEA in 2019, driving quality, people development, financial performance, and customer delivery for all FSP accounts across the region. She began her current role in January 2024.

Suchela Srivatsa
Senior Director, Clinical Operations
IQVIA 

Suchela Srivatsa is the senior director of clinical operations for IQVIA India, where she leads the centralized clinical FSP team. She is responsible for leading delivery of centralized hubs for multiple clients. Her roles include delivering KPIs and service level agreements to agreed quality, managing team performance, hiring, and onboarding. She also manages customers, creating solutions and keeping delivery on track. As an experienced professional with more than 26 years of experience, her clinical research roles have included clinical research associate, clinical project manager, regional lead, and centralization expert.

She also has more than 9 years of experience in centralization of clinical trial processes and lean process practice. Her specific experience includes centralizing and setting up targeted teams across various IQVIA regions, including India, China, Latin America, North America, Slovakia, the United Kingdom, and Bulgaria, in support roles for clinical trial leads and project management; eTMF; investigator payments; and centralization of RSU services.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/centralized-hubs